Neovacs S.Aの株式の価格
Neovacs S.Aの株式の価格 は何ですか。
Neovacs S.A.の株式の価格 は0.02です。
株式の価格 の定義は何ですか。
1株当たりキャッシュは、会社の手持ち現金を会社の発行済株式で割ったものです。
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
EURONEXTのセクタHealth Careにおける株式の価格 の企業と比べるNeovacs S.A
Neovacs S.Aは何をしますか。
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Neovacs S.Aと類似の株式の価格
- ELL Environmentalの株式の価格 は0.02です。
- Jervois Miningの株式の価格 は0.02です。
- Graphite Oneの株式の価格 は0.02です。
- Juniper IIの株式の価格 は0.02です。
- AMCI Acquisitionの株式の価格 は0.02です。
- Newborn Acquisitionの株式の価格 は0.02です。
- Neovacs S.Aの株式の価格 は0.02です。
- Saville Resourcesの株式の価格 は0.02です。
- Coolpadの株式の価格 は0.02です。
- Mexican Gold Miningの株式の価格 は0.02です。
- Voltの株式の価格 は0.02です。
- McLeod Russel Indiaの株式の価格 は0.02です。
- Hao Tian International Construction Investmentの株式の価格 は0.02です。